What Do Medical and Financial Research Have in Common? (Unfortunately). And, What Can You Do to Protect Yourself?

Dec 8, 2021 | Insights

Regrettably, only a fraction of published medical research is reproducible by other investigators. This is no surprise to those of us who contribute or follow medical advancements. Hundreds of reviews have documented tens of thousands of examples. From cancer biology...

Seeking Protection from Inflationary Spikes? Some thoughts.

Nov 11, 2021 | Insights

How might an investor protect themselves from the recent inflationary spike? How might they rationally act as the news is worsening? From a macroeconomic investor perspective, I offer caution in reacting to the news. The crescendo of news transmits multiple signals....

Why Covid Delta variant emergence may be positive for equities and bonds

Aug 24, 2021 | News, Articles, & PR

B. G., Opalesque Geneva According to Dr. Pat Welton, founder and CIO of Welton Investment Partners, a U.S.-based quantitative and ESG hedge fund manager, the Covid Delta variant emergence is likely an intermediate-term positive for equities and bonds. On a related...

Human vs. Machine in Investment Management – Time to Reframe the Debate

Jul 15, 2021 | Insights

Human versus machine. Which is superior? It’s a centuries-old question that continues to fascinate us. Regrettably, for investors, it often fascinates to the point of distraction. But, investors are only human. And when investors are both the questioner and a...

The Unprecedented $1.9T Stimulus Package and What It Might Mean for Investors in the Weeks and Months Ahead

Mar 12, 2021 | Insights

For macroeconomic investors the passage of this bill is a watershed event, but its implications for what comes next are likely even more consequential. The new $1.9T economic relief package that was passed by Congress this week and signed into law yesterday, is...